Frequency and Predictors of Symptomatic Intracerebral Hemorrhage in Patients with Ischemic Stroke Treated with Recombinant Tissue Plasminogen Activator outside Clinical Trials

Publisher： Karger

E-ISSN： 1421-9786|23|2-3|85-90

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.23, Iss.2-3, 2006-11, pp. : 85-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Uric Acid Levels on Outcome in Severe Ischemic Stroke Patients Treated with Intravenous Recombinant Tissue Plasminogen Activator

By  

European Neurology, Vol. 71, Iss. 3-4, 2013-12 ,pp. : 132-139

Karger

Access to resources Recommend Favorite

Does ICA Occlusion Frequently Have Intracerebral Hemorrhage after IV Tissue Plasminogen Activator Therapy for Ischemic Stroke?

By  

European Neurology, Vol. 65, Iss. 5, 2011-04 ,pp. : 245-249

Karger

Access to resources Recommend Favorite

Fatal Intracerebral Hemorrhage Associated with Administration of Recombinant Tissue Plasminogen Activator in a Stroke Patient on Treatment with Dabigatran

By  

Cerebrovascular Diseases, Vol. 32, Iss. 6, 2011-12 ,pp. : 614-615

Karger

Access to resources Recommend Favorite

Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 423-428

Karger

Access to resources Recommend Favorite

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite